Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome

BACKGROUND: Omalizumab is a very important drug for the treatment of chronic urticaria. Although omalizumab’s therapeutic efficacy has been demonstrated, data on real-world experiences in Korea, especially regarding chronic inducible urticaria (CIndU), are limited. This study attempted to compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Soo Hyun, Lim, Dong Jun, Chang, Sung Eun, Kim, Kwang Ho, Kim, Kwang Joong, Park, Eun Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274107/
https://www.ncbi.nlm.nih.gov/pubmed/35818702
http://dx.doi.org/10.3346/jkms.2022.37.e211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274107/
https://www.ncbi.nlm.nih.gov/pubmed/35818702
http://dx.doi.org/10.3346/jkms.2022.37.e211

Ejemplares similares